13F Data
13F filer · CIK 1825034

Euclidean Capital LLC

NEW YORK, NY · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$439.8M
+$47.5M vs prior
Positions
11
New / sold out
1 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $9.0M · sells $0
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewTEAMSHARES INC+1,099,974–+$9.0M

Biggest sells vs Q1 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $472.4MQ1 2021: $298.9MQ2 2021: $308.1MQ3 2021: $205.7MQ4 2021: $175.9MQ1 2022: $172.1MQ2 2022: $117.6MQ3 2022: $107.7MQ4 2022: $106.9MQ1 2023: $114.0MQ2 2023: $389.1MQ3 2023: $916.5MQ4 2023: $888.5MQ1 2024: $780.0MQ2 2024: $795.8MQ3 2024: $906.8MQ4 2024: $736.7MQ1 2025: $266.1MQ2 2025: $305.7MQ3 2025: $238.0MQ4 2025: $369.5MQ1 2026: $392.3MQ2 2026: $439.8M
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1VANGUARD INTL EQUITY INDEX FALLWRLD EX US3,243,484$271.6M61.76%
2VANGUARD INDEX FDSVALUE ETF520,000$113.3M25.76%
3ISHARES TRMSCI INDIA ETF369,600$18.3M4.15%
4ORIC PHARMACEUTICALS INCCOM989,410$10.7M2.44%
5TEAMSHARES INCCOM1,099,974$9.0M2.06%
6FOGHORN THERAPEUTICS INCCOM1,573,761$7.7M1.75%
7PMV PHARMACEUTICALS INCCOM2,627,643$3.5M0.80%
8ALECTOR INCCOM1,307,858$2.6M0.60%
9SURROZEN INCCOM NEW87,696$2.3M0.52%
10TENAYA THERAPEUTICS INCCOM1,015,705$750.7K0.17%
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.